,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-05-17 05:16:00,"Chicago, IL - May 17, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.01870703510940075,0.008391589857637882,0.9729014039039612,neutral,0.010315445251762867
1,2018-05-17 05:16:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2018-05-17 05:16:00,"Stocks recently featured in the blog include Home Depot HD , Merck MRK , Raytheon RTN , Eaton ETN and Sun Life Financial SLF .",0.019158782437443733,0.009647383354604244,0.9711938500404358,neutral,0.009511399082839489
3,2018-05-17 05:16:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
4,2018-05-17 05:16:00,Get #1Stock of the Day pick for free.,0.0864095613360405,0.03249066323041916,0.8810997605323792,neutral,0.05391889810562134
5,2018-05-17 05:16:00,"Here are highlights from Wednesday's Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.2265114039182663,0.00957189779728651,0.7639166712760925,neutral,0.2169395089149475
6,2018-05-17 05:16:00,"Today's Research Daily features new research reports on 16 major stocks, including Home Depot, Merck and Raytheon.",0.03913460671901703,0.009312189184129238,0.951553225517273,neutral,0.029822416603565216
7,2018-05-17 05:16:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
8,2018-05-17 05:16:00,"You can see all of today's research reports here >>>

Home Depot 's shares have gained +20.5% over the last year, outperforming the Zacks Retail Building Products industry's +14.1% increase.",0.9557778835296631,0.0255521759390831,0.018669912591576576,positive,0.9302257299423218
9,2018-05-17 05:16:00,"The Zacks analyst thinks that this performance is attributable to its five-year long trend of beating earnings estimates, which continued in first-quarter fiscal 2018.",0.8973563313484192,0.03622366487979889,0.06642001122236252,positive,0.8611326813697815
10,2018-05-17 05:16:00,"Further, both the top and bottom line improved year over year in the first quarter.",0.9516350626945496,0.018597137182950974,0.029767794534564018,positive,0.9330379366874695
11,2018-05-17 05:16:00,"Results gained from strength in core business as well as relentless focus on affording innovative products, boosting interconnected customer experience and driving productivity.",0.9371642470359802,0.014141994528472424,0.04869364947080612,positive,0.9230222702026367
12,2018-05-17 05:16:00,Steady housing market recovery and strong customer demand also remain tailwinds.,0.5508856773376465,0.26062843203544617,0.18848590552806854,positive,0.2902572453022003
13,2018-05-17 05:16:00,"Going into the fiscal second quarter, the company continues to witness strength in all lines of business in the first few weeks of May.",0.9497118592262268,0.017974695190787315,0.03231343999505043,positive,0.9317371845245361
14,2018-05-17 05:16:00,"Consequently, it provided an optimistic view for fiscal 2018.",0.7959024906158447,0.02047986164689064,0.1836176961660385,positive,0.7754226326942444
15,2018-05-17 05:16:00,"However, the top line lagged estimates mainly due to colder-than-normal weather that led to softness in the spring season categories, particularly garden.",0.050579410046339035,0.9232841730117798,0.02613644301891327,negative,-0.8727047443389893
16,2018-05-17 05:16:00,This softness also resulted in a decline in comparable transactions.,0.04782455787062645,0.9278411269187927,0.024334296584129333,negative,-0.880016565322876
17,2018-05-17 05:16:00,(You can read the full research report on Home Depot here >>> ).,0.012610534206032753,0.013505421578884125,0.973884105682373,neutral,-0.0008948873728513718
18,2018-05-17 05:16:00,"Shares of Merck have outperformed the Zacks Large Cap Pharmaceuticals industry year to date, gaining +5.2% versus a loss of -4.0%.",0.9072373509407043,0.07200556993484497,0.020756978541612625,positive,0.8352317810058594
19,2018-05-17 05:16:00,Merck beat estimates for earnings while missing the same for sales in Q1.,0.7860731482505798,0.173473060131073,0.04045375809073448,positive,0.6126000881195068
20,2018-05-17 05:16:00,"The Zacks analyst thinks that new products like Keytruda, Lynparza, and Bridion should continue to contribute meaningfully to the top line in 2018.",0.929100513458252,0.013417808338999748,0.05748166888952255,positive,0.9156827330589294
21,2018-05-17 05:16:00,Keytruda sales are gaining momentum with approval for additional indications especially in the first-line lung cancer setting as it is the only anti-PD-1 approved in this setting.,0.9277846813201904,0.014395815320312977,0.057819586247205734,positive,0.9133888483047485
22,2018-05-17 05:16:00,The Animal Health unit is also strong and remains a core growth driver for Merck.,0.8987900614738464,0.012291494756937027,0.08891847729682922,positive,0.8864985704421997
23,2018-05-17 05:16:00,"Meanwhile, Merck will continue to focus on cost-cutting initiatives to drive the bottom line.",0.8275777697563171,0.013668387196958065,0.1587538719177246,positive,0.8139094114303589
24,2018-05-17 05:16:00,"However, generic competition for several drugs and pricing pressure will continue to be overhangs on the top line.",0.09528374671936035,0.08432639390230179,0.8203898668289185,neutral,0.010957352817058563
25,2018-05-17 05:16:00,"Rising competitive pressure on the diabetes franchise and on products like Isentress (HIV), Zepatier (HCV) and Zostavax (vaccine) will remain headwinds in 2018.",0.027485288679599762,0.9463087916374207,0.026205893605947495,negative,-0.9188234806060791
26,2018-05-17 05:16:00,(You can read the full research report on Merck here >>> ).,0.012997591868042946,0.011902625672519207,0.9750998020172119,neutral,0.0010949661955237389
27,2018-05-17 05:16:00,"Raytheon 's shares have risen around +14.5% over the last six months, outperforming the Zacks Defense Equipment industry, which has increased +10.7% over the same period.",0.9537475109100342,0.023109745234251022,0.023142686113715172,positive,0.930637776851654
28,2018-05-17 05:16:00,"However, Raytheon kick started 2018 on a solid note.",0.9368367791175842,0.022622255608439445,0.04054095968604088,positive,0.914214551448822
29,2018-05-17 05:16:00,The company's first-quarter earnings and revenues comfortably surpassed expectations.,0.943874180316925,0.019681084901094437,0.03644473850727081,positive,0.9241930842399597
30,2018-05-17 05:16:00,The Zacks analyst thinks the company is one of the best-positioned large-cap defense players due to its non-platform centric focus.,0.8403079509735107,0.013453789055347443,0.14623825252056122,positive,0.8268541693687439
31,2018-05-17 05:16:00,"Due to its wide range of combat-proven defense products, the company continues to receive numerous orders from both Pentagon as well as foreign allies.",0.8637762665748596,0.012058040127158165,0.12416568398475647,positive,0.8517182469367981
32,2018-05-17 05:16:00,Raytheon's Patriot missile-defense systems have seen a number of buyers in recent times including international customers from Europe as well as the Middle East.,0.7979942560195923,0.01047047134488821,0.19153527915477753,positive,0.7875238060951233
33,2018-05-17 05:16:00,"However, factors like tough competition and political uncertainty continue to be major headwind for Raytheon.",0.03931212052702904,0.8255049586296082,0.13518288731575012,negative,-0.7861928343772888
34,2018-05-17 05:16:00,"Moreover, the company is overvalued compared to its broader industry in terms of EV/EBITDA ratio.",0.07818984240293503,0.8732091784477234,0.048600934445858,negative,-0.7950193285942078
35,2018-05-17 05:16:00,(You can read the full research report on Raytheon here >>> ).,0.013055223971605301,0.012064744718372822,0.974880039691925,neutral,0.000990479253232479
36,2018-05-17 05:16:00,Other noteworthy reports we are featuring today include Eaton and Sun Life Financial.,0.020934192463755608,0.0071660722605884075,0.971899688243866,neutral,0.013768119737505913
37,2018-05-17 05:16:00,"It's hard to believe, even for us at Zacks.",0.08736173063516617,0.254048228263855,0.6585900187492371,neutral,-0.1666865050792694
38,2018-05-17 05:16:00,"But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.",0.5075593590736389,0.04700726270675659,0.4454334080219269,positive,0.4605520963668823
39,2018-05-17 05:16:00,And this outperformance has not just been a recent phenomenon.,0.07535909861326218,0.015217346139252186,0.9094235301017761,neutral,0.060141753405332565
40,2018-05-17 05:16:00,Over the years it has been remarkably consistent.,0.6927107572555542,0.013971779495477676,0.29331743717193604,positive,0.6787389516830444
41,2018-05-17 05:16:00,"From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over.",0.7464389204978943,0.10755439102649689,0.14600670337677002,positive,0.6388845443725586
42,2018-05-17 05:16:00,Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.,0.5744941830635071,0.01052891369909048,0.41497692465782166,positive,0.5639652609825134
43,2018-05-17 05:16:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
44,2018-05-17 05:16:00,Get #1 Stock of the Day pick for free .,0.2226315140724182,0.024793583899736404,0.7525749206542969,neutral,0.1978379338979721
45,2018-05-17 05:16:00,Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.,0.06386703997850418,0.004654404241591692,0.9314785599708557,neutral,0.059212636202573776
46,2018-05-17 05:16:00,"Continuous coverage is provided for a universe of 1,150 publicly traded stocks.",0.036364275962114334,0.004866600502282381,0.9587691426277161,neutral,0.03149767592549324
47,2018-05-17 05:16:00,Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance.,0.054108913987874985,0.005191051866859198,0.9407000541687012,neutral,0.04891786351799965
48,2018-05-17 05:16:00,Recommendations and target prices are six-month time horizons.,0.013092893175780773,0.007127966266125441,0.9797791242599487,neutral,0.0059649269096553326
49,2018-05-17 05:16:00,"Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar.",0.044983625411987305,0.5624399185180664,0.3925764560699463,negative,-0.5174562931060791
50,2018-05-17 05:16:00,They're virtually unknown to the general public.,0.035764459520578384,0.0785161554813385,0.885719358921051,neutral,-0.04275169596076012
51,2018-05-17 05:16:00,"Yet today's 220 Zacks Rank #1 ""Strong Buys"" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015.",0.6580293774604797,0.017276067286729813,0.32469451427459717,positive,0.6407533288002014
52,2018-05-17 05:16:00,Its average gain has been a stellar +26% per year.,0.8422174453735352,0.0191669799387455,0.13861553370952606,positive,0.8230504393577576
53,2018-05-17 05:16:00,See these high-potential stocks free >>.,0.12527841329574585,0.05778927728533745,0.8169323205947876,neutral,0.0674891322851181
54,2018-05-17 05:16:00,"Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.01284766010940075,0.009404126554727554,0.9777481555938721,neutral,0.003443533554673195
55,2018-05-17 05:16:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
56,2018-05-17 05:16:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
57,2018-05-17 05:16:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
58,2018-05-17 05:16:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
59,2018-05-17 05:16:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
60,2018-05-17 05:16:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
61,2018-05-17 05:16:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
62,2018-05-17 05:16:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
63,2018-05-17 05:16:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
64,2018-05-17 05:16:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
65,2018-05-17 05:16:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
66,2018-05-17 05:16:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
67,2018-05-17 05:16:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
68,2018-05-17 05:16:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
69,2018-05-17 05:16:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
70,2018-05-17 05:16:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.015637893229722977,0.9741575717926025,neutral,-0.0054333265870809555
